Zhejiang Cancer Hospital
🇨🇳China
A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma
Phase 3
- Conditions
- Esophageal Cancer
- Interventions
- Radiation: Adjuvant radiotherapy
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2015-10-07
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 366
- Registration Number
- NCT02570893
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
Phase 2
- Conditions
- Gastric Cancer
- Interventions
- Other: HIPEC,Chemotherapy AND surgery
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2015-09-15
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02549911
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
Phase 3
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Procedure: segmentectomy
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 610
- Registration Number
- NCT02481661
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 135
- Registration Number
- NCT02385136
Comparable Study of Different Radiation Dose in Esophageal Carcinoma
Phase 3
- Conditions
- Esophageal Carcinoma
- Interventions
- Radiation: intensity modulated radiation therapy in both armsDrug: concurrent chemotherapy with radiation
- First Posted Date
- 2013-09-09
- Last Posted Date
- 2013-09-09
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT01937208
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection
Phase 2
- Conditions
- Non-small Cell Lung Cancer Stage IIIA
- Interventions
- Other: Neoadjuvant Chemoradiotherapy
- First Posted Date
- 2013-08-21
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT01926483
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma
Phase 3
- Conditions
- Stage IVC Nasopharyngeal CarcinomaEffects of Chemotherapy
- Interventions
- Drug: Recombinant Human Endostatin plus gemcitabine and cisplatin
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2015-01-01
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 362
- Registration Number
- NCT01915134
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer
Phase 2
- Conditions
- Locally Advanced Rectal Cancer
- Interventions
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2013-07-15
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT01899118
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer
Phase 2
- Conditions
- Gastric Cancer
- Interventions
- Procedure: surgery
- First Posted Date
- 2013-04-22
- Last Posted Date
- 2013-04-23
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01836991
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou,, Zhejiang, China
Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer
Phase 2
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2013-04-16
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01832948
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
© Copyright 2025. All Rights Reserved by MedPath